Wu Deng-Chyang, Wu I-Chen, Lee Jang-Ming, Hsu Hon-Ki, Kao Ein-Long, Chou Shah-Hwa, Wu Ming-Tsang
Department of Gastroentology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Am J Gastroenterol. 2005 Mar;100(3):588-93. doi: 10.1111/j.1572-0241.2005.40623.x.
Many researchers have reported the inverse relationship between Helicobacter pylori (H. pylori) infection and esophageal adenocarcinoma risk, but very few studies have examined the association between H. pylori infection and the development of esophageal squamous-cell carcinoma (ESCC). Therefore, the aim of this study is to evaluate the relationship between H. pylori infection and ESCC risk.
Subjects were cancer cases, pathologically proven to have ESCC, in two large medical centers in Kaohsiung metropolitan of southern Taiwan between August 2000 and May 2003. Controls were from the healthy subjects who lived in Kaohsiung metropolitan and voluntarily participated in one large multiyear of gene-environmental study. In total, 127 cases (116 males and 11 females) and 171 controls (161 males and 10 females) were recruited in the same period of time for interviews. H. pylori seropositivity was determined by an enzyme-linked immunosorbant assay measuring IgG.
A total of 28 (22.1%) and 74 (43.3%) out of 127 cases and 171 controls, respectively, had positive H. pylori infection. After adjusting for other covariates, subjects with positive H. pylori infections had a significantly reduced risk (adjusted odds ratio (AOR) = 0.51; 95% CI = 0.27-0.96; p= 0.037) of developing ESCC than those without. This result was even more pronounced in the groups of younger subjects, nonsmokers, or nondrinkers. In addition, among the 117 cancer patients who provided information about site of cancer lesion, the present study found that subjects with cancer lesions in the lower third of the esophagus had significantly fewer positive H. pylori infections (AOR = 0.34; 95% CI = 0.14-0.80; p= 0.013) than controls.
Our findings suggest that H. pylori infection may protect against the development of ESCC. Additional studies are needed to confirm these findings.
许多研究人员报告了幽门螺杆菌(H. pylori)感染与食管腺癌风险之间的负相关关系,但很少有研究探讨H. pylori感染与食管鳞状细胞癌(ESCC)发生之间的关联。因此,本研究的目的是评估H. pylori感染与ESCC风险之间的关系。
研究对象为2000年8月至2003年5月间台湾南部高雄市两个大型医疗中心经病理证实患有ESCC的癌症患者。对照组来自居住在高雄市且自愿参与一项大型多年基因-环境研究的健康受试者。在同一时期共招募了127例患者(116例男性和11例女性)和171名对照(161例男性和10例女性)进行访谈。通过酶联免疫吸附测定法测量IgG来确定H. pylori血清阳性。
127例患者和171名对照中分别有28例(22.1%)和74例(43.3%)H. pylori感染呈阳性。在调整其他协变量后,H. pylori感染呈阳性的受试者发生ESCC的风险显著降低(调整后的优势比(AOR)=0.51;95%置信区间(CI)=0.27-0.96;p=0.037),低于未感染的受试者。这一结果在年轻受试者、不吸烟者或不饮酒者组中更为明显。此外,在117名提供了癌症病变部位信息的癌症患者中,本研究发现食管下三分之一处有癌症病变的受试者H. pylori感染阳性的比例显著低于对照组(AOR = 0.34;95% CI = 0.14-0.80;p=0.013)。
我们的研究结果表明,H. pylori感染可能对ESCC的发生具有保护作用。需要进一步的研究来证实这些发现。